Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine



Recent Publications of Neal Kleiman, M.D.

Lev EI, Ramabadran RS, Guthikondha S, Patel R, Kleiman AL, Granada JF, DeLao,T, Kleiman NS. Effect of Ranitidine on the Anti-Platelet Effects of Aspirin in Healthy Human Subjects. Am J Cardiol. . 2007 Jan 1;99(1):124-128.

Lev EI, Ramchandani M, Garg R, Wojciechowski Z, Builes A, Vaduganathan M, Tripathy U, Kleiman NS. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. J Thromb Thrombolysis. 2007 Feb 3;

Guthikonda S, Lev, EI. †, Patel R, DeLao T, Bergeron A, Dong JF, Kleiman NS. Reticulated Platelets and Uninhibited COX-1 and COX-2 Decrease the Antiplatelet Effects of Aspirin. Journal of Thrombosis and Hemostasis. 2007 Mar; 5(3):490-6.

Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J. 2007 May;153(5):874-80.

Dzavik V, Cotter G, Reynolds HR, Alexander JH, Ramanathan K, Stebbins AL,Hathaway D, Farkouh ME, Ohman EM, Baran DA, Prondzinsky R, Panza JA, Cantor WJ, Vered Z, Buller CE, Kleiman NS, Webb JG, Holmes DR, Parrillo JE, Hazen SL, Gross SS, Harrington RA, Hochman JS. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J. 2007 Apr 25;